IL17A and arthritic joint disease: Clinical arthritis symptoms were reduced, most probably due to quercetin-mediated downregulation of proinflammatory cytokine and chemokine expression (e.g., TNF-α, IFN-γ, MCP1, IL-6, or IL-17) [20,21,22].